Lupin is one of India’s leading pharmaceutical companies with a strong presence in cardiovascular, respiratory, gastrointestinal, and central nervous system therapies.
Its key products include Atorvastatin (Tonact) for cholesterol control, Formoterol and Ciclesonide (Lotair Inhaler) for asthma, Nitazoxanide (Nizonide) for parasitic infections, Duloxetine (Dulot) for neuropathic pain, and Baricitinib (Barilup) for inflammatory disorders.
Lupin is globally recognized for quality, research excellence, and accessibility in over 100 countries.